Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia

ISSN

0390-6078

Date Issued

2014

Author(s)

Mueller-Thomas, Catharina

Rudelius, Martina

Rondak, Ina-Christine

Haferlach, Torsten

Huberle, Christina

Schmidt, Burkhard C.

Blaser, Rainer

Kremer, Marcus

Peschel, Christian

Germing, Ulrich

Platzbecker, Uwe

Goetze, Katharina S.

DOI

10.3324/haematol.2014.104760

File(s)

Name

e179.full.pdf

Size

108.82 KB

Checksum (MD5)

868ec07f1f486a52fc5a63017e2ae369